Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 1321-1330 of 13612

Page
per page
  1. β-Elemonic acid
    A4633 β-Elemonic acid
    Summary: A triterpene compound for apoptosis, inflammation and anticancer mechanisms
      ≥23.35 mg/mL
  2. GSK-A1
    BA1858 GSK-A1
    Summary: GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA inhibitor.
  3. p-Hydroxybenzaldehyde
    C6102 p-Hydroxybenzaldehyde
    Summary: An organic compound that can be used in fragrances and interacts with the GABAA receptor.
      insoluble in H2O; ≥39.1 mg/mL
  4. Tetrahydropalmatine
    A4632 Tetrahydropalmatine
    Summary: A selective antagonist that inhibits dopamine release in the amygdala for epilepsy
      ≥6.54 mg/mL
  5. EIDD-2749
    BA1857 EIDD-2749
    Summary: EIDD-2749 (4'-Fluorouridine) is an orally effective inhibitor.
  6. fumarate
    M1278 fumarate
    Summary: An unsaturated dicarboxylic acid with anti-inflammatory effects, usable for research on pregnancy-induced hypertension.
  7. Se-Methylselenocysteine
    A4631 Se-Methylselenocysteine
    Summary: A cancer chemopreventive agent with antioxidant activity that induces apoptosis
      ≥2.14 mg/mL
  8. Ombitasvir
    BA1856 Ombitasvir
    Summary: Ombitasvir is an inhibitor.
      ≥56.9 mg/mL
  9. Glycine, serine and threonine metabolism
    M1091 Glycine, serine and threonine metabolism
    Summary: A short-chain keto acid derivative produced by enzymatic cleavage of cystathionine.
      ≥48.1 mg/mL
  10. Catechin
    A4629 Catechin
    Summary: A flavonoid compound with antioxidant activity that inhibits cyclooxygenase-1
      ≥25.9 mg/mL

Items 1321-1330 of 13612

Page
per page